Early peek at data on Gilead coronavirus drug...
SWI Editorial Staff2020-04-16T16:24:55-07:00By ADAM FEUERSTEIN @adamfeuerstein and MATTHEW HERPER @matthewherper APRIL 16, 2020 A vial of the remdesivir, an investigational drug from Gilead.GILEAD SCIENCES VIA AP AChicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a ...